Le Lézard
Classified in: Covid-19 virus

2020 Market Report on Industry Convergence Boosting the Global Aircraft Electric Power Systems Market - COVID-19 Impact Analysis - ResearchAndMarkets.com


The "Industry Convergence Boosting the Global Aircraft Electric Power Systems Market, 2020" report has been added to ResearchAndMarkets.com's offering.

Electric power systems providers are part of a broader ecosystem within the aerospace industry supply chain, where hundreds of companies co-exist with varying levels of complementarity and dependency.

Commercial aviation has been seeing the highest levels of growth in recent years. Orders for new aircraft peaked in 2018, pushing the supply chain to capacity limits, which resulted in significant delays in deliveries and economic losses for OEMs and system integrators.

A series of transformations in the supply chain included several deals that led to a strong market concentration in the hands of large participants - now vertically integrated to improve efficiency, increase productivity, and remain competitive.

Given the integrated and interdependent supply chain, electric power system components manufacturers have not been immune to the various factors challenging the industry, notably the crisis triggered by the 737 MAX grounding order and the effects of COVID-19.

In light of such unprecedented crises, transformation plans are designed with an eye on industry recovery. Growth is expected to be slow and give rise to a new business model and supply chain.

There is much uncertainty with regard to the recovery process and the new market structure, but the post-pandemic normality is expected to bring profound changes in consumer behavior - in how they travel and interact with the industry. Increased safety regulations, as well as special attention to sustainability and healthcare issues, will help regain user confidence and return to the growth path that the market was able to maintain until 2018.

Key Features

Key Issues Addressed

Key Topics Covered:

1. Strategic Imperatives

2. Growth Opportunity Analysis, Global Aircraft Electric Power Systems Market

3. Growth Opportunity Analysis, Power Generation Segment

4. Growth Opportunity Analysis, Power Conversion Segment

5. Growth Opportunity Analysis, Power Distribution Segment

6. Growth Opportunity Analysis, Electric Storage Systems Segment

7. Growth Opportunity Analysis, Motorization Systems Segment

8. Growth Opportunity Universe, Aircraft Electric Power Systems Market

9. Appendix

10. Next Steps

For more information about this report visit https://www.researchandmarkets.com/r/o3drtr


These press releases may also interest you

at 14:45
The "Yeast - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. Global Yeast Market to Reach $11.6 Billion by 2030 The global market for Yeast estimated at US$6.2 Billion in the year 2023, is projected to reach...

at 14:15
Natuzzi chooses the stage of two among the most relevant global furniture events, High Point Market in North Carolina, and the Design Week in Milan, to unveil the dense program of events and projects that will mark the calendar of its 65th...

at 12:50
Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming June 11, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired QuidelOrtho Corporation ("QuidelOrtho"...

at 11:40
The "Global Needle Coke Market: Focus on Application, Type, Grade, End Use, and Country-Level Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The global needle coke market was valued at $3.05...

at 11:15
Expomed Eurasia, the most important medical exhibition between Europe and Asia, is ready to house more than a hundred companies, to discover new technological trends and the most innovative products which are going to change deeply the health market....

at 11:15
Nora Pharma, a Canadian pharmaceutical company, has received approval for its first Biosimilar product. Nora Pharma, a wholly owned division of Sunshine Biopharma, has received approval from Health Canada for the commercialization of NIOPEG® (a...



News published on and distributed by: